Keywords: acambis, six, month, loss, down, costs, fall

Acambis' six month loss down 16% as R&D costs fall; awaits warmbase deal

Article | 01 October 2007

Print This

UK vaccines developer Acambis loss for the six-month period ended June 30 was L19.3 million ($38.9 million), down 15.7% from the deficit it ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in